Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): Patient Workbook

by Sudie E. Back, Edna B. Foa, Therese K. Killeen, Katherine L. Mills, Maree Teesson

Overview

Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) is a cognitive-behavioral psychotherapy program designed for patients who have posttraumatic stress disorder (PTSD) and a co-occurring alcohol or drug use disorder. COPE represents an integration of two evidence-based treatments: Prolonged Exposure (PE) therapy for PTSD and Relapse Prevention for substance use disorders.

COPE is an integrated treatment, meaning that both the PTSD and substance use disorder are addressed concurrently in therapy by the same clinician, and patients can experience substantial reductions in both PTSD symptoms and substance use severity. Patients use the COPE Patient Workbook while their clinician uses the Therapist Guide to deliver treatment. The program is comprised of 12 individual, 60 to 90 minute therapy sessions. The program includes several components: information about how PTSD symptoms and substance use interact with one another; information about the most common reactions to trauma; techniques to help the patient manage cravings and thoughts about using alcohol or drugs; coping skills to help the patient prevent relapse to substances; a breathing retraining relaxation exercise; and in vivo (real life) and imaginal exposures to target the patient's PTSD symptoms.

Product Details

ISBN-13:	9780199334513
Publisher:	Oxford University Press
Publication date:	10/28/2014
Series:	Treatments That Work
Edition description:	Workbook
Pages:	192
Product dimensions:	8.40(w) x 10.90(h) x 0.60(d)

About the Author

Sudie E. Back, Ph.D., is a Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina, and a Staff Psychologist at the Ralph H. Johnson Veterans Affairs (VA) Medical Center in Charleston, SC. She is Director of the NIDA-sponsored Drug Abuse Research Training (DART) residency and summer research programs at the Medical University of South Carolina.

Edna B. Foa, Ph.D., is a Professor of Clinical Psychology in Psychiatry at the University of Pennsylvania, and Director of the Center for the Treatment and Study of Anxiety. Dr. Foa devoted her academic career to study the psychopathology and treatment of anxiety disorders, primarily obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD).

Therese K. Killeen, Ph.D., APRN, is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina. Dr. Killeen has over 20 years of experience working with adult and adolescent patients with comorbid PTSD and substance use disorders.

Katherine L. Mills, Ph.D., is an Associate Professor at the National Drug and Alcohol Research Centre, University of New South Wales. Dr. Mills is also Director of Treatment Research for the National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Mental Health and Substance Use in Australia.

Maree Teesson, Ph.D., is a National Health and Medical Research Council (NHMRC) Senior Research Fellow at the National Drug and Alcohol Research Centre, University of New South Wales, and Director of the NHMRC Centre of Research Excellence in Mental Health and Substance Use in Australia.

Bonnie Dansky Cotton, Ph.D., is a senior manager at Microsoft Corporation. She received her PhD in Clinical Psychology from Duke University and completed her internship at the Medical University of South Carolina. Prior to her career at Microsoft, Dr. Cotton was an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina.

Kathleen M. Carroll, Ph.D., is the Albert E. Kent Professor of Psychiatry at Yale University School of Medicine. She is an internationally renowned researcher on the development of behavioral therapies for substance use disorders. Dr. Carroll is Principal Investigator of the Center for Psychotherapy Development at Yale and Co-Principal Investigator of the New England Consortium of NIDA's Clinical Trials Network.

Kathleen T. Brady, MD, Ph.D., is a Distinguished University Professor and Associate Provost for Clinical and Translational Science at the Medical University of South Carolina. Dr. Brady is Director of the Women's Research Center, Director of the MUSC Clinical and Translational Research Center (CTSA), and Director of the Southern Consortium of NIDA's Clinical Trials Network.

Table of Contents

Chapter 1: Introduction

Chapter 2: Is This Program Right for You?

Chapter 3: Session 1

Chapter 4: Session 2

Chapter 5: Session 3

Chapter 6: Session 4

Chapter 7: Session 5

Chapter 8: Session 6

Chapter 9: Session 7

Chapter 10: Session 8

Chapter 11: Session 9

Chapter 12: Session 10

Chapter 13: Session 11

Chapter 14: Session 12

Appendices

Editorial Reviews

"Co-morbidity of PTSD and substance use disorders is as challenging as it is common in clinical practice. COPE offers the first integrated approach to treatment of these patients that has a solid foundation in evidence-based techniques and applies insights from basic neuroscience. Our experience with COPE for PTSD patients with alcohol addiction has been truly amazing." — Markus Heilig, MD PhD, Chief, Lab of Clinical and Translational Studies, NIAAA

"COPE is a much-needed integrated treatment for substance use and posttraumatic stress disorders. This excellent therapist manual, and its accompanying patient workbook, will provide important guidance for clinicians in delivering COPE, thereby expanding the possibility of providing high-quality integrated care for individuals suffering from both of these illnesses." — Shelly F. Greenfield, MD, MPH, Chief Academic Officer, Chief, Division of Women's Mental Health, and Director of Clinical and Health Services Research and Education, Division of Alcohol and Drug Abuse, McLean Hospital, and Professor of Psychiatry, Harvard Medical School

"COPE is a long awaited and much needed treatment manual, developed by an outstanding group of clinicians and researchers. COPE will allow exposure therapy, a highly effective treatment for PTSD, to be more readily available to patients who also have a substance use disorder. I recommend this book to anyone who treats patients who have both PTSD and a substance use disorder." —Sonya B. Norman, PhD, Associate Professor, Department of Psychiatry, University of California, San Diego

"This pair of books brings science-based treatment techniques and skills to a population of clients and therapists in urgent need. Based on years of careful and systematic development, these books provide critical training in how to deliver prolonged exposure therapy techniques in those with substance addictions. They are a groundbreaking addition to any trauma and addiction therapist's treatment collection." —Denise Hien, PhD, ABPP, Professor of Clinical Psychology, City College, Graduate Center of the City University of New York

"Clients will appreciate the user-friendly forms and worksheets to supplement their treatment with a qualified mental health professional. The workbook is also designed for clients who are motivated to work on their own.This workbook will benefit patients with concurrent PTSD and substance-use disorders when working with a trained clinician. The ultimate goal is to provide strategies and tools to enhance clients' quality of life by a reduction in both PTSD and substance-use disorders." —Nicholas Greco, Doody's Health Science Book Review

Featured in PsycCRITIQUES

From the Publisher

Reviewer: Nicholas Greco IV, MS, BCETS, CATSM, FAAETS (C3 Education and Research, Inc.)
Description: This addition to the Treatments That Work series focuses on treating patients with PTSD and substance abuse based on a cognitive-behavioral therapy (CBT) program. While CBT is not new, COPE is an integrated program that focuses on the treatment of PTSD and substance use disorder at the same time.
Purpose: The purpose is to help therapists treat clients with both PTSD and substance abuse disorders. There is a separate therapist guide that mirrors this patient workbook.
Audience: Clients will appreciate the user-friendly forms and worksheets to supplement their treatment with a qualified mental health professional. The workbook is also designed for clients who are motivated to work on their own.
Features: The patient workbook complements the therapist guide and takes clients step-by-step through the program and the principles of treatment. The program is divided into 12 sessions which mirror the therapist guide. The COPE program represents an integration of two evidence-based treatments: prolonged exposure therapy for PTSD and relapse prevention for substance-use disorder. The program covers the relationship between PTSD and substance-use disorders; common reactions to trauma; cognitive-behavioral techniques to help patients manage cravings and high-risk thoughts about using alcohol and drugs; breathing relaxation techniques; and imaginal exposure. The homework assignments emphasize core treatment principles and clients will find the worksheets and resources to be most helpful.
Assessment: This workbook will benefit patients with concurrent PTSD and substance-use disorders when working with a trained clinician. The ultimate goal is to provide strategies and tools to enhance clients' quality of life by a reduction in both PTSD and substance-use disorders.

Doody's Review Service